Diagnosis

LGMD type CR  PR 

The list of possible values is restricted to the LGMD forms specified in the consensus definition published in 2018.

Item type: single selection
Value ID Description Classification
LGMD D1

LGMD D1 DNAJB6-related (formerly LGMD 1D)

LGMD D2

LGMD D2 TNP03-related (formerly LGMD 1F)

LGMD D3

LGMD D3 HNRNPDL-related (formerly LGMD 1G)

LGMD D4

LGMD D4 calpain3-related (formerly LGMD 1I)

LGMD D5

LGMD D5 collagen 6-related (Bethlem myopathy dominant)

LGMD R1

LGMD R1 calpain3-related (formerly LGMD 2A)

LGMD R2

LGMD R2 dysferlin-related (formerly LGMD 2B)

LGMD R3

LGMD R3 α-sarcoglycan-related (formerly LGMD 2D)

LGMD R4

LGMD R4 β-sarcoglycan-related (formerly LGMD 2E)

LGMD R5

LGMD R5 γ-sarcoglycan-related (formerly LGMD 2C)

LGMD R6

LGMD R6 δ-sarcoglycan-related (formerly LGMD 2F)

LGMD R7

LGMD R7 telethonin-related (formerly LGMD 2G)

LGMD R8

LGMD R8 TRIM32-related (formerly LGMD 2H)

LGMD R9

LGMD R9 FKRP-related (formerly LGMD 2I)

LGMD R10

LGMD R10 titin-related (formerly LGMD 2J)

LGMD R11

LGMD R11 POMT1-related (formerly LGMD 2K)

LGMD R12

LGMD R12 anoctamin5-related (formerly LGMD 2L)

LGMD R13

LGMD R13 Fukutin-related (formerly LGMD 2M)

LGMD R14

LGMD R14 POMT2-related (formerly LGMD 2N)

LGMD R15

LGMD R15 POMGNT1-related (formerly LGMD 2O)

LGMD R16

LGMD R16 α-dystroglycan-related (formerly LGMD 2P)

LGMD R17

LGMD R17 plectin-related (formerly LGMD 2Q)

LGMD R18

LGMD R18 TRAPPC11-related (formerly LGMD 2S)

LGMD R19

LGMD R19 GMPPB-related (formerly LGMD 2T)

LGMD R20

LGMD R20 ISPD-related (formerly LGMD 2U)

LGMD R21

LGMD R21 POGLUT1-related (formerly LGMD 2Z)

LGMD R22

LGMD R22 collagen 6-related (Bethlem myopathy recessive)

LGMD R23

LGMD R23 laminin α2-related (formerly Laminin α2-related muscular dystrophy)

LGMD R24

LGMD R24 POMGNT2-related (formerly POMGNT2-related muscular dystrophy)

Genetic confirmation CR  PR  datestamped 

Specifies whether the diagnosis has been genetically confirmed. If the genetic test results are pending, the value must be No.

If the value is Yes, the genetic report date(s) and variants should be captured in one or more instances of the record Variant. As long as the value is No, registries should ask the data provider at each update to verify if this has changed. The datestamp of this item is the date when its value was last updated or marked as up-to-date (and not the report date, which is captured in the item Genetic report date).

The long-term goal for this dataset is to use the following definition of genetic confirmation:

  • For a dominant LGMD type, the individual must have a variant that is considered pathogenic or likely pathogenic for that diagnosis according to the ACMG guidelines.
  • For a recessive LGMD type, the indivudal must have at least one pathogenic variant plus another variant which is pathogenic, likely pathogenic or of uncertain significance, again in relation to the LGMD diagnosis and according to the ACMG guidelines.

However, many registries currently may not have the resources to verify genetic reports according to these criteria. Therefore, the value Yes for this item also applies to individuals who are reported to have a genetically confirmed diagnosis of LGMD, but where the registry is not able to verify the variant(s) and their pathogenicity.

Item type: yes/no
Usage in other datasets: SMADMD
Record

Variant CR         

For each variant that is related to the genetic confirmation as described in the item Genetic confirmation, an instance of this record must be provided. Further variants may be reported additionally; however, benign and likely benign variants are outside the scope of this dataset. All information collected in this record should be extracted from the genetic report and confirmed with a geneticist if necessary.

Variant HGVS CR 

Description of the variant according to HGVS nomenclature.

Item type: restricted text
Usage in other datasets: SMADMD
Genetic report date CR 

Date of the genetic report in which the variant described in Variant HGVS was reported.

Item type: date
Usage in other datasets: SMADMD
Pathogenicity CR 

Pathogenicity of the variant described in this record for the diagnosis specified in LGMD type according to the ACMG guidelines.

Item type: single selection
Value ID Description
Pathogenic

Pathogenic

Likely pathogenic

Likely pathogenic

Uncertain significance

Uncertain significance

Muscle biopsy performed CR  PR 

Specifies whether the individual has ever had a muscle biopsy.

This item refers to a muscle biopsy that confirmed the diagnosis specified in LGMD type.

Item type: yes/no
Usage in other datasets: DMD
Muscle biopsy date CR  PR 

Date of the muscle biopsy.

This item refers to the first muscle biopsy that confirmed the diagnosis specified in LGMD type.

Item type: date
Consistency rules:

If this value is provided, Muscle biopsy performed must be Yes.

Usage in other datasets: DMD
Muscle MRI performed CR  PR 

Specifies whether the individual has ever had a muscle MRI performed as part of the diagnostic process.

This item is not mandatory in case Genetic confirmation has the value Yes.

Item type: yes/no